Multipotent adipose-derived stromal/stem cells (ASCs) are candidates for use in cellular therapies for the treatment of a variety of conditions/diseases. Ex vivo expansion of freshly isolated ASCs may be necessary prior to clinical application to ensure that clinically relevant cell numbers are administered during treatment. In addition, cryopreserving cells at early passages allows for storage of freshly isolated cells for extended periods of time before expanding these cells for clinical usage. There are however several concerns that these laboratory-based procedures may alter the characteristics of the cells and in so doing decrease their regenerative potential. In this study we report on the impact of early rounds of cryopreservation (P0) and ex vivo expansion (P0 to P5) on the phenotypic characteristics and adipogenic differentiation potential of ASCs. Our results show that ASCs that upregulate CD36 expression during adipogenic differentiation gradually decrease with increasing expansion rounds. The consequent decrease in adipogenic differentiation capacity was evident in both gene expression and flow cytometry-based phenotypic studies. Successive rounds of expansion did not however alter cell surface marker expression of the cells. We also show that early cryopreservation of ASCs (at P0) does not affect the adipogenic differentiation potential of the cells.
tissue of origin 23, 24 . In addition, the primary physiological function of ASCs is to differentiate into adipocytes 25 . Increased intracellular lipid accumulation is a key morphologic characteristic associated with adipogenic differentiation, and is regulated by a well-defined cascade of transcription factors. CCAAT/enhancer binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ) are main regulators [26] [27] [28] , with PPARγ being an essential master regulator of the adipogenic differentiation process 27 . Upon activation, these transcription factors induce the upregulation of enzymes responsible for fatty acid biosynthesis, transport and incorporation into triglycerides, the main component of intracellular lipid droplet cores 28 . Proteins that play an important role in fatty acid uptake include CD36 (a fatty acid translocase), fatty acid binding protein 4 (FABP4), and others 28 . Adipose-derived stromal cells constitutively express low levels of CD36 on their surface, with a sub-population that expresses higher levels of CD36 29, 30 . Interestingly, CD36 is one of a few cell surface proteins that can be used to distinguish between ASCs and bone marrow-derived MSCs 31 .
We investigated the impact of early rounds of ex vivo expansion (P0 to P5) as well as initial cryopreservation following isolation (at P0) on the phenotypic characteristic and ex vivo adipogenic differentiation potential of ASCs. We found that a sub-population of ASCs with the ability to upregulate CD36 expression during adipogenic differentiation gradually decreases with increasing expansion rounds. The decrease in adipogenic differentiation potential of ASCs is significant from as early as P2. Cryopreservation at P0, however, did not affect the adipogenic differentiation potential of ASCs.
Materials and Methods
Materials. Collagenase Isolation of ASCs from adipose tissue. Adipose-derived stromal/stem cells (ASCs) were isolated from human adipose tissue as previously described 30, 32 . Subcutaneous adipose tissue was obtained from healthy donors that underwent elective liposuction surgery under general anaesthesia. Informed consent was obtained from all donors. Samples were anonymized immediately after collection and only limited demographic information (age and gender) was supplied ( Supplementary Table S1 ). The study was approved by the Research Ethics Committee, Faculty of Health Sciences, University of Pretoria (study numbers 218/2010, 421/2013 and 414/2015) and was conducted in accordance with the Declaration of Helsinki.
Cryopreservation of ASCs at Passage (P) 0. Freezing medium was prepared by adding DMSO (10%) to complete DMEM. ASCs at P0 (P0 ASCs) refers to cells in the SVF with the ability to adhere to the surface of the tissue culture flasks after initial seeding. The adherent cells were allowed to reach 80-90% confluence after which they were dissociated as described below. After two washing steps (using PBS), cells were resuspended in freezing medium at a concentration of approximately 1 × 10 6 cells/ml and transferred to cryovials (Greiner Bio-One, Kremsmünster, Austria). Cryovials were transferred to an isopropanol freezing container (Nalgene 1 °C/ min freezing container, Thermo Fisher Scientific/ Nalge Nunc International, Penfield, NY, USA) for overnight freezing in a −80 °C freezer (Thermo Fisher Scientific, Waltham, MA, USA). After overnight freezing, the cryovials were transferred to a dewar (Thermo Fisher Scientific, Waltham, MA, USA) for storage in liquid nitrogen vapour. After 10-14 months in storage, the cryovials were removed from the dewar, and briefly thawed at room temperature to allow for quick transfer of the semi-frozen cell solution into 25 ml of pre-warmed (37 °C) complete DMEM culture medium. Cells were centrifuged at 300 g for 5 minutes. The cell pellet was washed once more with PBS and transferred to a T75 culture flask. The cells were maintained as described below. At P4, cells were seeded into 6-well plates (P5) and induced to differentiate into adipocytes as described below. The experimental design for assessing the effect of cryopreservation on the adipogenic differentiation of ASCs is summarized in Supplementary data Fig. S1 .
Expansion of ASCs.
Cells were maintained at 37 °C/5% CO 2 in complete DMEM culture medium. At 80-90% confluence, the cells were dissociated for 10 minutes at 37 °C using 0.25% trypsin-EDTA, and seeded at a density of 5 × 10 3 cells/cm 2 into T75 cultures flasks (for expansion) and 6-well plates (for adipocyte differentiation). Cultures were expanded for five passages. The experimental design for assessing the effect of passaging (ex vivo expansion) on the adipogenic differentiation of ASCs is summarized in Supplementary data Fig. S2 .
In vitro adipocyte differentiation. In vitro adipogenic differentiation of ASCs was performed as previously described 30,32 . Adipocyte quantification using flow cytometry. Prior to staining, the cells were dissociated as described above. The cell suspension was carefully transferred (using a plastic Pasteur pipette) to 15 ml tubes. Due to the fragile nature of adipocytes, no washing steps were performed. One millilitre (1 ml) aliquots of the cell suspensions were stained with Nile Red (20 ng/ml final concentration), Vybrant ® DyeCycle TM Violet (VDC Violet; 2.5 µM final concentration) and mouse anti-human CD36-APC. After a 20 min incubation at room temperature, cells were analysed using a Gallios flow cytometer. Nile Red was excited by a 488 nm laser and fluorescent emission signals were collected using the FL2 (575/30 nm BP) detector. Non-induced ASCs were used to optimise the PMT voltage settings as well as to set the signal-to-noise threshold of the Nile Red fluorescence. After initial optimisation, all instrument settings were kept constant for the duration of the study. Flow Check TM Pro (Beckman Coulter, Miami, USA) fluorospheres were run daily to validate instrument performance. Flow cytometry data was analysed using Kaluza flow cytometry data analysis software (Version 1.5, Beckman Coulter, Miami, USA).
Fluorescence microscopy. Cells (both non-induced and induced) were cultured in 6-well plates as described above. Prior to fluorescence microscopy imaging, both non-induced and induced cultures were stained with Vybrant ® DyeCycle TM Violet (2.5 μg/ml final concentration) and NR (final concentration 50 ng/ml). After a 20-minute incubation period (37 °C/5% CO 2 ), the culture medium was removed and the wells rinsed with PBS to remove non-adherent cells and unbound residual dye. Fluorescence images were captured using an AxioVert A1 inverted fluorescence microscope (Carl Zeiss, Gottingen, Germany) equipped with an AxioCam Cm1 camera (Carl Zeiss). Single channel images were captured and subsequently converted into overlay images. Nile Red was captured using Filter Set 9 (excitation BP 450-490, emission LP 515; Carl Zeiss) to visualise yellow-gold fluorescence and Vybrant ® DyeCycle TM Violet was captured using Filter Set 49 (excitation G 365, emission BP 445/50; Carl Zeiss) to visualise nuclei. Images were initially captured using AxioVision software (Version 4.8.2). In order to optimally visualise intracellular lipid droplets, all images were enhanced, but not manipulated, post-acquisition using Image J imaging software 33 . Enhancement of images was done by adjusting contrast and brightness settings.
RNA Isolation and RT-qPCR.
RNA was isolated and reverse-transcription-quantitative polymerase chain reactions (RT-qPCR) performed as previously described 30, 32 . The primers (IDT, Coralville, IA, USA) and their sequences for the genes of interest as well as the reference genes used, are summarised in Supplementary Table S2 .
Statistical analysis.
For RT-qPCR data, relative gene expression was calculated using the modified comparative CT method (ΔΔC T ) as indicated below:
where GOI indicates gene of interest (non-induced or induced sample) and REF indicates reference genes The following reference genes were used: PPIA, TBP, YWHAZ (Table S1 )
where IND refers to induced sample and NI refers to non-induced sample. Relative fold-increases were calculated using amplification efficiencies determined for each of the genes of interest through standard curves.
where E refers to the amplification efficiency obtained for the specific gene of interest.
Results are expressed as mean ± standard deviation (SD) or standard error of the mean (SEM). Outliers were identified using the ROUT statistical test (Q = 0.1%) and excluded from statistical analysis. The Mann-Whitney test was used to determine statistical significance between groups. GraphPad PRISM 7 (Version 7.02, Graphpad Software, San Diego, USA) was used for all statistical analyses. Differences between groups were considered to be significant if the P values were ≤ 0.05, with *, **, and *** corresponding to P ≤ 0.05, P < 0.01, and P < 0.001, respectively.
Results
In order for cells to be characterized as MSCs they need to be plastic adherent, express a pre-defined set of cell surface proteins and have the ability to differentiate into adipocytes, chondrocytes and osteoblasts 31 . Only adipogenic differentiation potential was investigated in this study.
ASCs were dislodged from cell culture vessel surfaces and cell viability assessed before being used in downstream experiments. No significant differences in viability were observed between non-induced and induced www.nature.com/scientificreports www.nature.com/scientificreports/ cultures or between different passages (Supplementary data Table S3 ). The percentage viability for all passages combined (P0 to P5) was 95.69 ± 2.85% and 96.08 ± 3.23%, for non-induced and induced samples, respectively.
All undifferentiated ASCs used in this study were positive for CD44, CD73, CD90 and CD105 and negative for CD45. No significant differences were observed between the percentage of ASCs displaying the above-mentioned phenotype at the various passages ( Fig. 1 ; last column). The proportion of ASCs displaying a CD44 + /CD73 + / CD90 + /CD105 + /CD45 − co-expression profile was 97.28 ± 1.34% at P0, 97.23 ± 0.83% at P1, 95.78 ± 1.93% at P2, 96.53 ± 2.31% at P4 and 96.95 ± 1.74% at P5 ( Fig. 1 ; last column). In contrast to the uniformity observed for the markers mentioned above, CD34 and CD36 expression varied at the various passages. The respective sub-populations present at the various passages, however, did not differ significantly between passages. As we have previously reported 30 , the majority of ASCs express CD36 dimly (CD36 dim ) with a sub-population of cells that express CD36 at a higher intensity (CD36 ++ ) (Fig. 1 ). The main phenotypic difference between undifferentiated and differentiated (adipogenic) ASCs was the upregulation of CD36 expression during adipocyte differentiation ( Fig. 1) , confirming the findings reported by several other groups that CD36 is associated with adipocyte differentiation 30, [34] [35] [36] .
Intracellular lipid droplet accumulation is a key morphological feature associated with adipocyte differentiation 26, 37 (Fig. 2a,c) . Intracellular lipid droplet accumulation increases the side scatter (SS) signal (indicative of cellular complexity) of the cells when analysed by flow cytometry (Supplementary data Fig. S3 ). Not all ASCs exposed to adipogenic induction medium differentiated into adipocytes (Figs 1 and 2) . Interestingly, ASCs exposed to adipogenic differentiation medium but which did not proceed to full adipogenic differentiation (no detectable intracellular lipid droplet accumulation based on their SS profiles) displayed similar phenotypic profiles as non-induced cells ( Fig. 1) .
Ex vivo expansion and cryopreservation are often used in the laboratory either to increase cell numbers or preserve cells for future use. Ideally, ASCs should maintain their therapeutic potential, including differentiation potential, during ex vivo expansion and cryopreservation. In the first series of experiments we investigated the effect of cryopreservation on the expansion rate and the ability of ASCs to undergo adipogenic differentiation. ASCs (P0) were cryopreserved for 10-14 months after which the cells were removed from cryostorage and expanded to P5 ( Supplementary Fig. S1 ). At P5, ASCs were induced to differentiate into adipocytes. The level of adipocyte differentiation observed in the previously cryopreserved ASCs was compared to the degree of adipocyte differentiation observed for ASCs (P5) from the same culture that had not previously been cryopreserved.
The relative expansion rate was calculated as the expansion period (days) required for ASC cultures to reach 80-90% confluence at each passage. As confluence estimates can be subjective, and in an attempt to minimize potential error in judgment, confluence estimates were performed by the same person for the duration of the study.
The formula used was:
− .
Relative expansion period days ( )
(1)
Number of days in culture i e at P total number of viable cells harvested i e P total number of viable cells seeded i e P
The average number of days from initial seeding (P0) to replating (P1) was 7.4 ± 0.9 days. The total number of cells harvested at P0 confluence (80-90%) was lower than the initial seeding density (5 × 10 5 nucleated SVF cells/ cm 2 ), resulting in an initial period of negative expansion when the equation was applied ( Fig. 3 ). At P1, the relative expansion period required for the primary ASC cultures to reach 80-90% confluence was 21.34 ± 4.41 days, which was significantly (p = 0.013, n = 5) longer than the relative expansion period (7.73 ± 1.77 days) required to achieve confluence at P2 ( Fig. 3 ). No significant differences were observed between expansion periods observed at P2, P3 (10.01 ± 6.04 days), P4 (14.16 ± 6.20 days) and P5 (12.17 ± 8.51 days) ( Fig. 3) .
The relative expansion periods required for previously cryopreserved ASCs to reach 80-90% confluence were monitored at P2, P3, P4 and P5. A significantly (p = 0.008, n = 5) longer expansion period (13.76 ± 1.22 days) was observed for ASCs that underwent cryopreservation at P2 when compared to the relative expansion period (7.73 ± 1.77 days) observed at P2 for ASC cultures not previously cryopreserved ( Fig. 3 ). However, no significant differences in the relative expansion period were observed at P3, P4 and P5 between cultures that did and did not undergo cryopreservation (Fig. 3 ). The relative expansion periods observed for previously cryopreserved ASC cultures were 12.21 ± 4.87 days at P3, 8.65 ± 2.27 days at P4 and 9.34 ± 1.77 days at P5 ( Fig. 3) .
Adipogenic differentiation was assessed by investigating gene expression levels of key adipogenesis-associated genes as well as quantifying the proportion of differentiated ASCs with increased CD36 expression and intracellular lipid content at various time points during the 21-day differentiation period. No significant differences were observed in adipocyte differentiation at P5 between cells that did and did not undergo cryopreservation ( Fig. 4 ). ASCs with detectable levels of intracellular lipid accumulation were observed from day 7 onwards for both non-cryopreserved and cryopreserved ASCs ( Fig. 4) . At day 7, 4.53 ± 4.65% and 3.20 ± 0.74% of induced non-cryopreserved and cryopreserved ASCs displayed increased levels of intracellular neutral lipid accumulation. The percentage of induced ASCs (not exposed and exposed to cryopreservation) increased on day 14 to 11.57 ± 7.22% and 15.43 ± 5.74%, respectively ( Fig. 4 ). On day 21, the percentage of cells with increased intracellular neutral lipid accumulation increased to 13.07 ± 7.88% for non-cryopreserved ASCs and to 19.85 ± 4.40% for cryopreserved ASCs (Fig. 4) . Less than 1% of the non-induced (control) ASCs displayed detectable levels of intracellular neutral lipid accumulation at day 0. No noticeable intracellular neutral lipid accumulation was observed in non-induced (control) ASCs throughout the 21-day culture period (Fig. 2a) .
The transcription factor, peroxisome proliferator-activated receptor gamma (PPARG), was upregulated in induced cells when compared to the relative gene expression levels detected in non-induced cells (data not shown). There were however no noticeable differences in PPARG gene expression levels between non-cryopreserved and www.nature.com/scientificreports www.nature.com/scientificreports/ cultures previously cryopreserved ( Fig. 5b-d ). Relative FABP4 (p = 0.016) and ADIPOQ (p = 0.016) gene expression levels (normalised to corresponding non-induced cultures) were significantly higher in cryopreserved ASCs when compared to cultures not previously cryopreserved (Fig. 5c,d) .
We also investigated the impact of ex vivo expansion on the ability of ACS to undergo adipogenic differentiation. ASCs used in this set of experiments had not previously been cryopreserved. At P0, 47.29 ± 12.18% of differentiated ASCs displayed an increase in intracellular neutral lipid content (Fig. 6 ). The proportion of ASCs that were able to differentiate into adipocytes decreased to 36.79 ± 5.75% at P1, 24.02 ± 15.94% (p = 0.0377, compared to P0) at P2, 19.64 ± 14.32% (p = 0.0068 compared to P0) at P4 and 21.95% ± 10.68 (p = 0.0092 compared to P0) at P5 (Fig. 6 ). The percentage of non-induced cells with detectable levels of intracellular neutral lipid was less than <5% (Fig. 6) , and no significant changes in lipid accumulation were observed in these cells over the 21-day culture period.
Adipocyte differentiation is associated with upregulation of CD36 cell surface expression which precedes intracellular lipid accumulation (Fig. 7a,b) 30 . In vitro data suggest that intracellular lipid accumulation only occurs when the maximum level (based on fluorescence intensity; maximum right shift) of CD36 cell surface expression is reached (Fig. 7a,b) 30 . We observed that the total proportion of ASCs (undifferentiated and differentiated) expressing intermediate/high levels of CD36 (CD36 ++/+++ ) gradually decreased as the number of ex vivo expansion rounds increased (Fig. 7a,b ), reaching significance (p = 0.029, n = 4; when compared to P0), for both undifferentiated and differentiated cells at P5 (Fig. 7c) . At P0, 22.50 ± 16.63% of undifferentiated ASCs expressed intermediate/high levels of CD36 (Fig. 7c ). The percentage of undifferentiated ASCs expressing intermediate/high levels of CD36 decreased to 12.92 ± 16.32% at P2 and 2.50 ± 3.10% at P5 (Fig. 7c ). The proportion 35 .01 ± 18.51% at P2 and 15.58 ± 8.06% at P5 (p = 0.029, when compared to undifferentiated cells) ( Fig. 7c) .
Combining Nile Red staining (intracellular lipid detection) and CD36 cell surface staining allows the identification of three distinct populations during adipocyte differentiation, namely undifferentiated ASCs (Nile Red Neg /CD36 Neg ), ASCs with increased CD36 cell surface expression, but no detectable levels in intracellular lipid (Fig. 7a,b) . Interestingly, we observed a fourth population in this study (Nile Red Pos /CD36 Neg ) that was present at a higher frequency in early passages (P0) compared to later passages (P5) (Fig. 7a,b) . We observed that all four sub-populations gradually decreased as the cells were expanded ex vivo (Fig. 7D) . The Nile Red Pos /CD36 Pos sub-population reached significance (p = 0.057, n = 4) at P5 (Fig. 7D) . In contrast, we observed a gradual increase in the frequency of the undifferentiated (Nile Red Neg /CD36 Neg ) cell population during ex vivo expansion reaching significance (p = 0.029, n = 4) at P5 (Fig. 7d) .
The relative levels of expression of adipogenesis-associated genes were also investigated ( Fig. 8) . A gradual decrease in PPARG, CD36 and ADIPOQ gene expression (relative fold increase, normalized to corresponding non-induced cultures) was observed with increasing rounds of ex vivo expansion (Fig. 8a,b,d) . However, none of the decreases observed were significant. The lack of significance is likely due to the high degree of inter-culture variability observed. Interestingly, we observed an increase in FABP4 gene expression at P2 for two of the cultures studied (Fig. 8c) . The reason for the upregulation of FABP4 at P2 is unclear.
Discussion
Adipose tissue, often harvested in relatively large quantities during cosmetic surgical procedures such as lipoaspirate and abdominoplasty, is a rich source of multipotent ASCs 38 . Adipose tissue harvested during these procedures is considered biological waste and is thus associated with minimal ethical concerns. All of these factors make adipose tissue an increasingly popular source from which multipotent MSCs can be harvested for therapeutic use.
Various studies have shown that donor age, body mass index (BMI) and the general state of health of the donor might have an impact on the therapeutic potential of ASCs 39 . Collectively, these studies suggest that ASCs isolated from young, healthy, lean donors hold the greatest potential for clinical benefit. It would thus be beneficial if ASCs with enhanced therapeutic potential could be isolated, expanded and cryopreserved for future clinical applications. However, it is important to understand the impact of both cryopreservation and ex vivo expansion on the differentiation potential of these cells 40 . DiGirolamo and colleagues (1999) showed that osteogenic differentiation was maintained during ex vivo expansion of bone marrow-derived MSCs, while the potential of these cells to undergo adipogenic differentiation decreased during expansion 41 . Halleux and colleagues (2001) also showed that clones of bone marrow-derived MSCs fail to undergo adipogenic and chondrogenic differentiation after ex vivo expansion 42 . Using bovine adipose-derived stromal cells, Zhao and colleagues (2012) showed that ex vivo expansion resulted in a decrease in adipogenic and chondrogenic differentiation potential, but not osteogenic differentiation potential 43 . Safwani and colleagues (2011) showed, using human ASCs, that extensive ex vivo expansion (≥P5) resulted in decrease expression of adipogenic differentiation associated genes 44, 45 .
The ability of ASCs to differentiate into adipocytes not only allows for the study of the process of adipogenesis in vitro, but may also contribute to the clinical application of ASC-associated cell therapy products. One such clinical application is fat grafting, a well-established technique often used in soft tissue reconstruction/augmentation procedures 11 . In clinical practice, fat grafts are often supplemented with stem cells, more specifically ASCs, a practice commonly referred to as cell-assisted lipotransfer (CAL) 46, 47 . The enhanced benefits observed using CAL are contributed to by the ability of ASCs to differentiate into adipocytes, resulting in enhanced volume retention of the fat graft 46, 47 .
In this study, adipocytes were characterized based on their expression of CD36 cell surface protein and increased intracellular lipid levels. We showed in a recent study 30 , and confirmed in this study, that CD36 www.nature.com/scientificreports www.nature.com/scientificreports/ expression is upregulated during adipocyte differentiation and precedes intracellular lipid accumulation. We also observed that increasing rounds of ex vivo expansion results in a gradual decline in the proportion of ASCs that display increased CD36 expression levels and a consequent decrease in intracellular lipid accumulation during adipogenic differentiation, i.e. in ASCs that differentiated into adipocytes. CD36, a fatty acid translocase, plays an important role during adipocyte differentiation and upregulation of CD36 expression 30, 35, 48 . suggested that isolation of CD36-expressing cells from SVF, would select for cells with enhanced adipogenic potential 35 .
All ASCs used in this study uniformly expressed CD73, CD44, CD90 and CD105, while not expressing CD45, a cell surface protein associated with mature leukocytes. The ASCs used in this study therefore adhered to the phenotypic cell surface expression profile, with the exception of CD34, recommended by the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT) 31 . In contrast to the uniformity of expression observed for these markers and aligned with several recent reports 15, 20, [49] [50] [51] , we observed variable expression of the phosphoglycoprotein, CD34. The function of CD34 in MSCs is largely unknown. Suga and colleagues (2009) isolated CD34-negative and CD34-positive ASCs sub-populations and investigated their respective biological functions 52 . They observed differences in the proliferation rate, differentiation potential and gene expression profiles between the two sub-populations and concluded that the CD34-positive ASC population is more immature (undifferentiated) and that the loss of CD34 expression is a function of ASC commitment to undergo differentiation 52, 53 . Other investigators oppose this view and suggest that the variable expression of CD34 observed ex vivo is due to the cells being cultured in sub-optimal ex vivo conditions, which lack the factors necessary to support CD34 expression in vivo 50 .
The reason for the ex vivo expansion-associated decrease in ASC adipogenic potential is unknown. Selective loss of ASC sub-populations with adipogenic differentiation potential during culturing is a possible explanation. Selich and colleagues (2016) showed, using umbilical cord-derived MSCs, that a significant level of clonal selection occurs during the in vitro expansion of these cells 54 . Post and colleagues (2008), using MSCs isolated from murine bone marrow, suggested that bone marrow-derived MSCs contain precursors that are committed either to adipogenic or osteogenic differentiation 55, 56 . It is possible that similar progenitors are present during the early (i.e. P0 and P1) passages of ASC cultures, and that these are gradually lost during extended ex vivo expansion, resulting in the diminished adipocyte differentiation potential of ex vivo expanded ASCs. Another explanation may be the gradual loss of cells, such as adipose tissue-associated macrophages (ATMs), which are known to play an important role in adipose tissue homeostasis. Adipose tissue-associated macrophages (ATMs) are one of the more abundant cell types present in adipose tissue 57, 58 . As a result of their ability to adhere to plastic, ATMs are present as a relatively large proportion of the total cell population during the initial passages of ASC culture 57 (Supplementary Fig. S4) . Several in vitro studies suggest that there is crosstalk between ATMs and ASCs [59] [60] [61] and that ATMs may influence the adipogenic differentiation potential of ASCs 58,62-64 . The majority of these studies suggest that ATMs suppress adipogenic differentiation in vitro, but the exact impact of ATMs on ASC adipogenic differentiation is not fully understood. In a recent study, He and colleagues (2018) showed that cell culture supernatant from M1 (pro-inflammatory) macrophage cultures promoted adipogenic differentiation, while culture supernatant from M0 (undifferentiated) and M2 (anti-inflammatory) macrophages suppressed adipogeneic differentiation 65 . Contrary to these findings, Lee and colleagues (2016) suggested that CD44 positive-M2 macrophages promote adipogenic differentiation 62 . These authors suggest that the catalytic products, 9-hydroxyoctadecadienoic acid (9-HODE) and 13-hydroxyoctadecadienoic acid (13-HODE) of arachidonate 15-lipoxygenase (Alox15), an enzyme highly expressed by M2 macrophages, promote CD36-mediated uptake of oxidised low-density lipoprotein (OXLDL), and in so doing contribute to intracellular lipid accumulation 62 . These authors further suggest that 9-HODE and 13-HODE drive the differentiation of white adipose precursors into brown adipocytes 62 .
We also investigated the impact of cryopreservation on the adipocyte differentiation potential of ASCs that underwent a limited number of rounds of ex vivo expansion. We did not observe a significant change in the ability of ASCs to undergo adipocyte differentiation in cells that had been cryopreserved at P0 for 10-14 months. Our observation is in line with similar observations made by several other investigators 40, [66] [67] [68] . Lee and co-workers 66 cryo-stored unprocessed lipo-aspirates for up to one year and found no significant difference in the adipogenic differentiation potential of ASCs isolated from these lipo-aspirates and expanded to P1/P2, when compared to the adipogenic differentiation potential of ASCs isolated from freshly harvested lipo-aspirate tissue. Goh and co-workers 68 cryopreserved ASCs at P1 for at least one month, after which the cells were removed from cryo-storage, followed by immediate assessment of their adipogenic differentiation potential. These investigators found that cryopreservation had no significant effect on the proliferation rate or the adipocyte differentiation capabilities of ASCs. Gonda and co-workers 40 and Kokai and co-workers 67 likewise found no decrease in the adipocyte differentiation potential of ASCs after cryopreservation (for 6 months and 10 years, respectively). Interestingly, we observed higher relative levels of FABP4 and AdipoQ gene expression in ASCs that were cryopreserved at P0. To our knowledge, only a limited number of studies have investigated the effect of cryopreservation on the expression of adipogenic-associated genes using ASC cultures from the same donor. Yong and colleagues 69 investigated the effect of cryopreservation (3 months) on the phenotypic expression, proliferation rate and differentiation potential of ASCs. They found that cryopreservation had no impact on the proliferation rate and differentiation potential, including adipogenenic differentiation potential 69 . In our study the increased expression of end-stage adipogenic genes, such as FABP4 and AdipoQ, observed in cryopreserved ASC cultures correlates with the slightly higher level of adipogenic differentiation observed in these cultures at day 21 post-induction. The reasons for the higher levels of FABP4 and AdipoQ expression observed in ASC cultures previously cryopreserved requires further investigation. Duan and Lopez (2016) , using canine multipotent stromal cells, suggested that cryopreservation changes the expression profiles of these cells 70 . Shaik and colleagues (2017) showed that the induction of heat shock proteins (HSPs) enhances ASC stemness 71 . It has been reported that cold shock increases the expression of HSPs 72 . It is therefore possible that HSPs are upregulated during the initial phases of cryopreservation, which in turn enhances the multipotent characteristics of ASCs when they are thawed and expanded post-cryopreservation. However, this hypothesis needs experimental confirmation.
Our data suggest that cryopreservation does not have a significant impact on the rate of ASC expansion. As expected, cryopreserved cells initially took slightly longer to reach 80-90% confluence. This may in part be due to the exposure of these cells to DMSO. DMSO was diluted and removed as soon as the cells were removed from liquid nitrogen storage. However, it may still affect the proliferation ability of these cells. The cells, however, are soon restored to normal function and no significant differences in the periods required to expand these cells to P5 were observed when non-cryopreserved ASCs (54.2 ± 6.4 days, P2 to P5) were compared to those that had been cryopreserved (58.2 ± 1.1 days, P2 to P5).
In summary, we have investigated the effect of ex vivo expansion (P0-P5) on the adipocyte differentiation potential of ASCs as well as which pre-adipocyte sub-populations are affected during the process. We also investigated if cryopreservation soon after isolation (P0) affects the adipocyte differentiation potential of ASCs when expanded ex vivo. Our data suggest that cryopreservation does not affect the ability of ASCs to differentiate into adipocytes. However, we found that an ASC sub-population that upregulates CD36 expression when induced to differentiate into adipocytes, decreased with increasing rounds of ex vivo expansion, resulting in a gradual decrease in the ability of ASC cultures to undergo adipogenic differentiation.
